Filter
577
Text search:
injectable
medicines
Featured
Recommendations
105
New Publications
181
Language
Document type
No document type
313
Guidelines
118
Studies & Reports
63
Manuals
38
Fact sheets
14
Strategic & Response Plan
13
Training Material
12
Situation Updates
4
Resource Platforms
1
Infographics
1
Countries / Regions
Kenya
23
Global
22
Western and Central Europe
20
India
18
Nepal
17
Malawi
16
South Africa
15
Ethiopia
13
Zambia
12
Namibia
12
Eastern Europe
12
Nigeria
11
Uganda
11
Tanzania
11
Bangladesh
11
Rwanda
9
Myanmar / Burma
9
Africa
9
Liberia
8
Senegal
8
Sierra Leone
6
Ghana
6
Latin America and the Carribbean
6
Haiti
5
Congo, Democratic Republic of
4
Zimbabwe
4
Middle East and North Africa
4
Guinea
3
Burkina Faso
3
Syria
3
Benin
3
South–East Asia Region
3
Eastern Europe and Central Asia
3
Tajikistan
3
Russia
3
Georgia
3
Mali
2
Cameroon
2
Philippines
2
Lebanon
2
Mozambique
2
Lesotho
2
East and Southern Africa
2
West and Central Africa
2
Asia
2
Timor Leste/ East Timor
2
Iran
2
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Somalia
1
Pakistan
1
South Sudan
1
Iraq
1
Jordan
1
Turkey
1
Cambodia
1
Gambia
1
Sudan
1
Eswatini/ Swaziland
1
North Macedonia
1
Serbia
1
Ukraine
1
Botswana
1
Greece
1
Libya
1
Albania
1
Armenia
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
228
Clinical Guidelines
95
Women & Child Health
51
Public Health
32
Key Resources
19
Pharmacy & Technologies
10
Capacity Building
6
Toolboxes
TB
85
HIV
58
Pharmacy
40
Malaria
21
Caregiver
19
COVID-19
17
Mental Health
15
AMR
12
NCDs
11
NTDs
9
Ebola & Marburg
8
Conflict
5
Rapid Response
4
Refugee
4
Health Financing Toolbox
4
Natural Hazards
2
Polio
1
Social Ethics
1
Planetary Health
1
In this guideline, WHO recommends that long-acting injectable cabotegravir (CAB-LA) may be offered as an additional HIV prevention option for people at substantial risk of HIV infection. CAB-LA is an injec
...
L’immunisation: un chantier inachevé
recommended
Un rapport de plaidoyer de la Fédération internationale des Sociétés de la Croix-Rouge et du Croissant-Rouge
publié en partenariat avec l’Alliance mondiale pour les vaccins et l’immunisation (GAVI)
Update, 2023. En 2021, les résultats préliminaires des études d’observation du projet CARAMAL (Community Access to Rectal Artesunate for Malaria) n’ont pas confirmé l’impact sur la mortalité observé dans l’essai contrôlé de 2009. Par conséquent, en janvier 2022, l’OMS a publié un
...
Information note. In 2021, preliminary results of observational studies from the Community Access to Rectal Artesunate for Malaria (CARAMAL) project did not confirm the mortality impact observed in the controlled trial in 2009. Consequently, in January 2022, WHO released an information note on recta
...
Actualización de 2023. Nota informativa. En 2021, los resultados preliminares de los estudios observacionales del proyecto de Acceso Comunitario al Artesunato Rectal para el Paludismo (CARAMAL, por sus siglas en inglés) no confirmaron el impacto en la mortalidad observado en el ensayo controlado d
...
PMPB/INS-GUIDE/02
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceuticals may constitute as much as 40% of the national he
...
Essential medicines are those that satisfy the priority health care needs of a population. They are selected with due regard to disease prevalence and public health relevance, evidence of efficacy and safety and comparative cost-effectiveness. They
...
The essential medicines are those that meet the priority needs of the healthcare of the population. While reviewing the 5th edition of the essential Medicines, special attention focused on the heal
...
6th edition, 2010. | Published in collaboration with World Health Organisation and Clinton Health Access Initiative.
PQM conducted an assessment of the medicine quality assurance and quality control systems in Rwanda during November 9-13, 2009. Medicine quality assurance remains to be developed in Rwanda: the country has neither a medicine regulatory authority (MRA) nor a national medicine quality control laborato
...
The Priority medicines for mothers and children 2011 list was updated following the 18th Expert Committee Meeting
on Selection and Use of Medicines, the release of new treatment guidelines and fee
...
Fourth Edition
6th edition